BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5125476)

  • 1. Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1971 Mar; 6(3):215-7. PubMed ID: 5125476
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
    Seiden LS; Martin TW
    Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 4. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of the reserpine-induced suppression of the conditioned avoidance response by L-dopa: correlation of behavioral and biochemical differences in two strains of mice.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Feb; 159(2):422-8. PubMed ID: 5638661
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1973 Jan; 10(1):9-12. PubMed ID: 4540511
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats.
    Ahlenius S; Engel J
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):349-60. PubMed ID: 4255378
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine: mediator of brain polysome disaggregation after L-dopa.
    Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
    Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotype hyperactive behaviour produced by dopamine in the absence of noradrenaline.
    Scheel-Krüger J; Randrup A
    Life Sci; 1967 Jul; 6(13):1389-98. PubMed ID: 6035768
    [No Abstract]   [Full Text] [Related]  

  • 11. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    Lotti VJ; Porter CC
    J Pharmacol Exp Ther; 1970 Apr; 172(2):406-15. PubMed ID: 5441162
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J; Grabowska M; Mogilnicka E
    Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
    [No Abstract]   [Full Text] [Related]  

  • 13. Aromatic amino acid decarboxylase inhibitors.
    Porter CC
    Fed Proc; 1971; 30(3):871-6. PubMed ID: 5575298
    [No Abstract]   [Full Text] [Related]  

  • 14. Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Sep; 163(1):84-90. PubMed ID: 5673718
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of apomorphine on motility in rats.
    Maj J; Grabowska M; Gajda L
    Eur J Pharmacol; 1972 Feb; 17(2):208-14. PubMed ID: 5026397
    [No Abstract]   [Full Text] [Related]  

  • 16. The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat.
    Wallach MB; Gershon S
    Eur J Pharmacol; 1972 Apr; 18(1):22-6. PubMed ID: 5031271
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and behavioral effects of l-DOPA methyl ester in cats treated with reserpine.
    Hanson LC; Utley JD
    Psychopharmacologia; 1965 Jul; 8(2):140-4. PubMed ID: 5853737
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetics of audiogenic seizures. 3. Time response relationships between drug administration and seizure susceptibility.
    Schlesinger K; Boggan WO; Freedman DX
    Life Sci I; 1970 Jul; 9(13):721-9. PubMed ID: 4394568
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of the reserpine-induced suppression of the conditioned avoidance response in the cat by L-DOPA.
    Seiden LS; Hanson LC
    Psychopharmacologia; 1964 Oct; 6(4):239-44. PubMed ID: 5830803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.